Silver's 5,000-Year War With Infection — And What They Did With It
Ancient physicians used it. A boxer from the Philadelphia slums got rich off it. It saved millions of newborns from blindness. Now it's back in hospitals fighting superbugs — and still barely mentioned.
The Barnes Foundation in Philadelphia holds one of the greatest art collections on earth.
Renoir. Cézanne. Matisse. Picasso. Van Gogh.
Worth an estimated $25 billion today.
It was bought with silver.
Specifically: a silver protein compound in tiny glass bottles
dropped into the eyes of newborn infants
to stop them going blind from their mothers' infections.
That story is documented. That story is real. That story is almost never told.
Silver's medical history doesn't start in a laboratory. It starts with observation — the same observation made independently by civilizations separated by thousands of miles and thousands of years. Silver doesn't let things rot.
Hippocrates, writing around 400 BC, recorded the use of silver preparations to treat ulcers and promote wound healing. Roman physicians documented silver compounds in pharmacopeias by 69 BCE. Across ancient civilizations — Phoenician, Greek, Roman, Persian — silver vessels were preferred for storing water on long voyages. They didn't have the language of microbiology. They had the data: water stored in silver stayed drinkable longer. Soldiers who ate from silver plates had better survival rates in the field. The mechanism was unknown. The pattern was consistent.
Hippocrates records silver preparations for wound treatment and ulcer care. Writes that silver has beneficial healing and anti-disease properties.
Silver compounds documented in Roman pharmacopeias as antiseptic treatments. Silver vessels standard for water storage among military campaigns.
Wealthy families eat from silver plates and drink from silver cups during plague outbreaks. The association between silver and protection from disease is well established — and not wrong. Colloidal silver is prescribed by European physicians for centuries as a general antiseptic.
Surgeon J. Marion Sims adopts silver wire sutures for gynecological procedures, noting dramatically fewer post-operative infections compared to silk or catgut alternatives. Silver wire becomes standard in surgical settings.
None of this was fringe. None of it was folk medicine. It was the mainstream medical consensus of its era, used by the most respected physicians of their time, for the simple reason that it worked — and nothing else worked better.
Here is a specific date that changed millions of lives. You've almost certainly never been taught it.
In the late 19th century, gonorrheal ophthalmia neonatorum was one of the leading causes of blindness in the industrialized world. Mothers infected with gonorrhea — often unknowingly, since the disease was frequently asymptomatic in women — could pass the bacteria to their newborns during delivery. The infection hit the infant's eyes. Up to 10% of all newborns in European maternity hospitals developed it. Of those, roughly 20% suffered significant vision damage. Three to five percent went completely blind. In Germany alone, it accounted for 25–40% of all cases of childhood blindness. Blind schools were full of children who'd been healthy at birth.
On June 1, 1880, Dr. Carl Siegmund Franz Credé — a German obstetrician working in Leipzig — began applying a 2% silver nitrate solution to the eyes of every newborn in his care immediately after delivery. The results were immediate and documented. Infection rates dropped from 10% to effectively zero. He published his findings in three papers between 1881 and 1883. Within two decades, Credé's procedure was mandatory by state law in most US jurisdictions.
Before Credé's procedure: 10–10.8% of newborns in European maternity hospitals developed gonorrheal eye infections. Of those: 20% sustained permanent vision damage. 3–5% went completely blind. Blindness from this single cause accounted for 25–40% of all childhood blindness in Germany.
After Credé's procedure: Infection rates dropped to under 0.13% in 13 years of documented follow-up across multiple institutions. The leading preventable cause of childhood blindness in the industrialized world was essentially eliminated — not by an antibiotic. By silver.
Albert C. Barnes was born in 1872 in the slums of South Philadelphia. His father — a butcher who'd been badly wounded fighting for the Union — couldn't provide much. Barnes put himself through medical school at the University of Pennsylvania by tutoring, boxing semiprofessionally, and running side hustles. He graduated with his MD at age 20. Then he went to Germany to study advanced chemistry.
There, he met Hermann Hille, a German chemist. They identified the central problem with silver nitrate — the compound Credé had used so effectively — which was that it was caustic. Silver nitrate works by releasing silver ions rapidly and aggressively. Against bacteria, that's effective. Against the delicate mucous membranes of the eye, throat, or reproductive tract, it burns. Physicians had been managing this trade-off for twenty years.
Barnes and Hille found a solution. They bound silver to protein — creating a compound that retained silver's antimicrobial properties but released its ions slowly, gently, in a form that was, as contemporary physicians described it, "bland and soothing" on sensitive tissue. They named it Argyrol. Barnes deliberately chose not to patent it — doing so would require disclosing the exact formula — and instead built a legal fortress of trademark protection around the brand name, pursuing anyone who tried to copy it with what contemporaries described as ferocious litigation.
Argyrol was adopted across the United States and Europe as the standard treatment for gonorrheal infections of the eye, ear, nose, and throat. The French military used it during World War I to control venereal disease among troops. Throughout the 1920s it treated soldiers exposed to poison gas.
Barnes ran his company until July 1929. By extraordinary timing — or extraordinary intuition — he sold the A.C. Barnes Company to Zonite Products Corporation for $6 million at the precise peak of Argyrol's commercial success, months before the stock market crash that began the Great Depression. He immediately invested in tax-exempt bonds. He lost almost nothing in the crash.
With that silver money, Barnes had spent two decades buying art. He'd been guided initially by his friend William Glackens. Over 900 paintings by 1920. The largest private collection of Renoir in the world. Major holdings of Cézanne, Matisse, Picasso, Van Gogh, Modigliani. He established the Barnes Foundation in 1922 in Merion, Pennsylvania. Today it holds over 4,000 objects estimated at $25 billion.
Every Renoir in the Barnes. Every Cézanne. Every Matisse. Bought with silver protein eyedrops used to protect newborns from blindness. That is not a metaphor. That is the documented history.
When penicillin became widely available after World War II, silver's mainstream medical role contracted almost overnight. This was not a conspiracy. It was a rational clinical choice: antibiotics were more targeted, more reliable for specific bacterial infections, and easier to administer systemically. Silver can't be taken orally and absorbed into the bloodstream the way an antibiotic can. For internal infections, antibiotics were clearly superior.
Silver retreated to niche roles: wound care, burn treatment, ophthalmology. The colloidal silver boom of the early 20th century — when hundreds of silver-based preparations flooded the market with varying quality and extravagant claims — faded. Some of those claims deserved to fade. Argyria, the condition where excessive silver intake causes the skin to turn permanently blue-gray, had been documented throughout the early 1900s. It wasn't dangerous beyond the cosmetic effect, but it was real and it was caused by poorly made, too-concentrated silver preparations taken in large quantities over long periods.
In 1999, the FDA issued a final rule stating that colloidal silver products marketed as over-the-counter drugs for any disease condition were not generally recognized as safe and effective. This applied specifically to OTC drug marketing claims — not to silver's established clinical uses in wound dressings, medical devices, and prescription applications, which continued.
Here is where the story gets genuinely modern — and genuinely important.
The rise of antibiotic-resistant bacteria has produced a medical crisis that's been building for decades and is now undeniable. MRSA. Pseudomonas aeruginosa. Klebsiella pneumoniae. Multi-drug resistant pathogens that defeat standard antibiotic protocols are responsible for an estimated 1.27 million deaths globally per year according to a 2022 Lancet study — more than HIV/AIDS or malaria. The WHO calls antimicrobial resistance one of the greatest threats to global health.
And researchers looking for alternatives to antibiotics that bacteria haven't had centuries to develop resistance against have rediscovered something the ancient world knew and the 19th century confirmed:
Silver kills bacteria through multiple simultaneous mechanisms. It disrupts the cell membrane. It generates reactive oxygen species that damage bacterial DNA. It inhibits protein synthesis. It interferes with DNA replication. Bacteria find it extremely difficult to develop resistance to something that attacks them from four directions at once.
Wound Care: Silver sulfadiazine cream, developed in the 1960s, is still a standard burn treatment in hospitals globally. Modern silver-impregnated wound dressings — including nanosilver hydrogels — are in active clinical use for chronic wounds, diabetic ulcers, and post-surgical infections.
Medical Devices: Silver-coated catheters, endotracheal tubes, and surgical instruments are in use specifically to prevent biofilm formation and device-related infections. A July 2026 peer-reviewed study demonstrated that silver nanoparticle-functionalized catheters showed broad-spectrum efficacy against ten multi-drug-resistant clinical isolates including Pseudomonas aeruginosa and Klebsiella pneumoniae.
Nanoparticle Research: Silver nanoparticles (AgNPs) are one of the most active areas in antimicrobial research. Multiple 2025–2026 peer-reviewed studies demonstrate efficacy against MRSA, MRSE, and other drug-resistant pathogens in wound healing applications. The mechanism is better understood now than ever: simultaneous multi-target bacterial disruption that makes resistance development dramatically harder than with single-mechanism antibiotics.
Space Medicine: Russian cosmonauts have used silver-ionized water for sterilization on space missions for decades. NASA has studied silver-based water purification systems for long-duration spaceflight.
Silver has a 2,400-year documented medical record that is not folk medicine. It eliminated neonatal blindness in the 1880s. It funded $25 billion worth of great art through the only mechanism available before antibiotics. It survived the antibiotic era in clinical wound care and is experiencing serious scientific rehabilitation as antibiotic resistance becomes an existential medical problem.
The people who tell you silver is a quack remedy and the people who tell you it cures everything are both wrong. The actual story — documented, sourced, spanning centuries — is more interesting than either of those positions.
A boxer from South Philadelphia figured this out in 1902 and used it to buy Renoir. That's not a metaphor. That's what happened.
"Few may know how he earned a place in the history of medicine — specifically through his development of Argyrol, the unique compound that was the source of his fortune."
— Sylvia Karasu, Hektoen International, on Albert C. Barnes